Sunshine Biopharma (SBFM) Inventory Average (2019 - 2026)

Sunshine Biopharma (SBFM) has reported Inventory Average for 8 consecutive years, with $12.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average rose 1.67% year-over-year to $12.6 million; the trailing twelve-month figure through Jun 2026 stood at $12.6 million (up 1.67% YoY), and the FY2025 full-year result was $12.4 million, up 45.48% from the prior year.
• Inventory Average slipped to $12.6 million in Q2 2026 per SBFM's latest filing, from $13.3 million in the prior quarter.
• Across five years, Inventory Average topped out at $13.8 million in Q4 2025 and bottomed at $143573.0 in Q1 2022.
• Historically, Inventory Average has averaged $7.3 million across 5 years, with a median of $7.4 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Inventory Average soared 2337.76% in 2023, then advanced 1.67% in 2026.
• Over 5 years, Inventory Average stood at $1.8 million in 2022, then soared by 188.01% to $5.1 million in 2023, then surged by 105.81% to $10.5 million in 2024, then soared by 30.51% to $13.8 million in 2025, then dropped by 8.15% to $12.6 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $12.6 million, $13.3 million, and $13.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.